Literature DB >> 28270680

Metastatic Epstein-Barr Virus-Positive Lymphoepithelioma-Like Cholangiocarcinoma in a Young Man With Ulcerative Colitis.

Nicholas Y Tan1, Shounak Majumder2, Meera Sridharan3, Sarah E Kerr4, Rondell P Graham4, Karthik Ravi2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28270680     DOI： 10.1038/ajg.2016.565

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  10 in total

1.  Lymphoepithelioma-Like Cholangiocarcinoma: A Rare Finding With Good Outcomes.

Authors:  Ismail Labgaa; Spiros Hiotis; Stephen C Ward
Journal:  J Clin Gastroenterol       Date:  2016-03       Impact factor: 3.062

2.  Intrahepatic Cholangiocarcinoma With Lymphoepithelioma-like Carcinoma Components Not Associated With Epstein-Barr Virus: Report of a Case.

Authors:  Suefumi Aosasa; Tadashi Maejima; Akifumi Kimura; Kiyoshi Nishiyama; Hiromi Edo; Hiroshi Shinmoto; Tatsumi Kaji; Sho Ogata; Kazuo Hatsuse; Kazuo Hase; Junji Yamamoto
Journal:  Int Surg       Date:  2015-04

Review 3.  Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis.

Authors:  Xavier Mariette; Marco Matucci-Cerinic; Karel Pavelka; Peter Taylor; Ronald van Vollenhoven; Rebecca Heatley; Claire Walsh; Richard Lawson; Alan Reynolds; Paul Emery
Journal:  Ann Rheum Dis       Date:  2011-09-01       Impact factor: 19.103

4.  Lymphoepithelioma-like cholangiocarcinoma: an Epstein-Barr virus-associated tumor.

Authors:  Y M Jeng; C L Chen; H C Hsu
Journal:  Am J Surg Pathol       Date:  2001-04       Impact factor: 6.394

Review 5.  Epstein-Barr virus: 40 years on.

Authors:  Lawrence S Young; Alan B Rickinson
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

6.  Epstein-Barr virus-associated lymphoepithelioma-like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome.

Authors:  Anthony W H Chan; Joanna H M Tong; Mandy Y M Sung; Paul B S Lai; Ka-Fai To
Journal:  Histopathology       Date:  2014-09-02       Impact factor: 5.087

7.  Metastatic colon cancer from extrahepatic cholangiocarcinoma presenting as painless jaundice: case report and literature review.

Authors:  Benjamin W Vabi; Jeffrey Carter; Rong Rong; Minhua Wang; James G Corasanti; John F Gibbs
Journal:  J Gastrointest Oncol       Date:  2016-04

8.  Mortality and cancer in pediatric-onset inflammatory bowel disease: a population-based study.

Authors:  Anaïs Peneau; Guillaume Savoye; Dominique Turck; Luc Dauchet; Mathurin Fumery; Julia Salleron; Eric Lerebours; Karine Ligier; Francis Vasseur; Jean-Louis Dupas; Olivier Mouterde; Claire Spyckerelle; Djamal Djeddi; Laurent Peyrin-Biroulet; Jean-Frédéric Colombel; Corinne Gower-Rousseau
Journal:  Am J Gastroenterol       Date:  2013-08-13       Impact factor: 10.864

9.  Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).

Authors:  Fernando Magro; Laurent Peyrin-Biroulet; Harry Sokol; Xavier Aldeger; Antonia Costa; Peter D Higgins; Joel C Joyce; Konstantinos H Katsanos; Anthony Lopez; Teresa Mas de Xaxars; Elena Toader; Laurent Beaugerie
Journal:  J Crohns Colitis       Date:  2013-05-27       Impact factor: 9.071

10.  Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.

Authors:  Aliya F Gulamhusein; John E Eaton; James H Tabibian; Elizabeth J Atkinson; Brian D Juran; Konstantinos N Lazaridis
Journal:  Am J Gastroenterol       Date:  2016-03-22       Impact factor: 10.864
  10 in total
  1 in total

Review 1.  Lymphoepithelioma-like carcinoma in liver not associated with Epstein-Barr virus: a report of 3 cases and literature review.

Authors:  Kai Zhang; Changcheng Tao; Zonggui Tao; Fan Wu; Songlin An; Jianxiong Wu; Weiqi Rong
Journal:  Diagn Pathol       Date:  2020-09-23       Impact factor: 2.644
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.